Grootste objectieve website voor
 complementaire en alternatieve geneeskunde
Beoordeling
Definities
Maatschappij
Kosteneffectief
Science
Onderwijs
Student
Politiek
Gezondheidscolumn
Ziekten
AIDS en HIV
Alzheimer
Angst en Depressie
Artrose
Astma
Beroerte
Burnout
Candida
Cholesterol
Chronische pijn
Crohn
Depressie
Diabetes
Dystrofie
Eczeem
Fibromyalgie
Hartproblemen
Hoge Bloeddruk
Hooikoorts
Kanker
Migraine en hoofdpijn
Multiple sclerose
Parkinson
Prostaatvergroting
Reuma
RSI
Slaapproblemen
Vermoeidheid
Vrouwenziekten
Meest gebruikte behandelwijzen
Acupunctuur
Manuele Therapie
Supplementen
Homeopathie
Fytotherapie
Natuurgeneeswijze
Antroposofie
Andere behandelwijzen
Energetisch
Bioresonantie
Traditioneel
Biologisch
Manipulaties
Lichaamswerk
Meditatie
Hypnose
Yoga
Qigong
Biofeedback
Overige
Boekbespreking
Spreuken
Tegengif
Documenten
TV programma Uitgedokterd
Engish Articles
DISCLAIMER
Home arrow English arrow New hope for chronic pain patients: breakthrough
New hope for chronic pain patients: breakthrough
Share |
siaarti.jpg

There is a new painkiller available in Germany, based on a body own and all natural compound which proved to be effective and without any troublesome side effects, professor Jan M. Keppel Hesselink, will point out at an important medical congres in Italy on November 24-26, 2011. Leading international pain experts, such as the German professor Ralph Baron will also speak at that congres. 

Keppel hesselink, holding a chair in molecular pharmacologist at the University of Witten/Herdecke in Germany, will present a major breakthrough in chronic pain treatment during the anual neurological congress for Italian anesthesiologists and painspecialists (SAARTI). While nearly all painkillers available inhibit pain via the nerve cells, Keppel Hesselink pointed out that a totally different and natural approach via the modulation of the so called glia cells has been overseen. 

Great improvement in pain and better functionality 

This approach now has resulted in dramatic improvements of pain in many patients. He expected this treatment to revolutionize the field of pain treatment. On every nerve cell there are 10 glia cells in our nervous system, and these activated cells are responsable for keeping the body in a chronic painstate.

The new compound modulates the glia cells via a body own regulating system and calms these cells, leading to less pain.

Keppel Hesselink pointed out that this compound, palmitoylethanolamide (Normast) has been tested for safety and efficacy in clinical trials in more than 2000 patients, has been used already in more than 800.000 patients Italy, Spain and in the Netherlands.

 

New impressing data: less pain and better functionality with Normast 

He presented new data on a study in 636 patients suffering from severe sciatic and backpain. Both Normast 300 mg and Normast 600 mg daily reduced the pain significantly, 600 much better than 300 and 300 again better than placebo.

Its clinical effects were superior compared to the best painkiller in this field available for patients. And furthermore, due to much less pain, the patients were able to function better, as measured on an objective functional scale. This is the first time pain reduction and improvement of functionality could be demonstrated for a body own compound modulating the glia.

Normast has now become available also in Germany as food for medical purposes.

New painkillers are extremely important, since 50 years already there have been no new superior drugs helping patients with chronic pain, Normast could be such an improvement. While Normast is active as a painkiller and a inhibitor of inflammation, it can be used in many different indications.

picture_7.jpg

 

Share |

Commentaar
Schrijf commentaar
Naam:
Onderwerp:
Security Image

Powered by JoomlaCommentCopyright (C) 2006 Frantisek Hliva. All rights reserved.Homepage: http://cavo.co.nr/

 
© Copyright 2012 Stichting voor innovatief onderzoek en onderwijs
van complementaire behandelwijzen. Alle rechten voorbehouden.